SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GUFIC BIOSCIENCES

BSE: 509079 29 Jun 2025
Healthcare
₹ 348.8
Gufic BioSciences Ltd. specializes in Pharmaceuticals within the Healthcare sector.

GUFIC BIOSCIENCES - Share Price & Details

Market Cap
₹3,567
High /Low
504.0 / 285.0
Stock P/E
51.2
Book Value
₹59.9
Dividend Yield
0.03
ROCE
13.0
ROE
₹12.3
Face Value
1.0
PEG Ratio
NA
EVEBITDA
₹28.0
Debt
336
CMP / FCF
NA
Debt to equity
₹0.56
NP Ann
69.6
High price all time
504.0
Piotroski score
₹5.0
Graham Number
96.8
No. Eq. Shares
10.0
Net CF
₹14.6
Net profit
69.6
Price to book value
5.93
Interest Coverage
₹5.07
Low price all time
2.46
Industry PE
32.0
Reserves
₹591
Free Cash Flow
₹51.8

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
GUFIC BIOSCIENCES LTD.NANANANA3,56751.2
Orchid Pharma LimitedNANANANA349935.1
GUJARAT THEMIS BIOSYN LTD.390.84119.98377.361.1349871.7

Peer Comparison Chart


About GUFIC BIOSCIENCES

Gufic BioSciences Ltd., with Security Code 509079, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Gufic Biosciences Ltd (BOM:509079) Q4 2025 Earnings Call Highlights: Strategic Shifts and ... By GuruFocus

(03 Jun 2025)
Gufic Biosciences Ltd (NSE:GUFI) (BOM:509079) has successfully shifted its sales teams to focus on hospitals with high prescribing potential...
Read more →

Gufic BioSciences Shows Mixed Technical Trends Amid Market Fluctuations

(03 Jun 2025)
Gufic BioSciences, a small-cap pharmaceutical company, has experienced a recent stock price decline. Technical indicators present mixed signals,...
Read more →

Gufic BioSciences Faces Volatility Amid Broader Market Decline and Mixed Performance Signals

(02 Jun 2025)
Gufic BioSciences has faced a notable decline today, continuing a downward trend over the past two days. The stock's performance shows mixed...
Read more →

Gufic BioSciences Outperforms Sector Amid Broader Market Rally and Small-Cap Gains

(12 May 2025)
Gufic BioSciences has experienced significant stock activity, outperforming its sector amid a broader market rally. The stock has shown consecutive gains...
Read more →

Gufic BioSciences Faces Mildly Bearish Trends Amid Strong Management Efficiency and Profit Decline

(23 Apr 2025)
Gufic BioSciences has recently experienced an evaluation adjustment, reflecting a mildly bearish technical trend influenced by various metrics.
Read more →

Gufic Biosciences Limited's (NSE:GUFICBIO): Top Key Executive Jayesh Choksi is the most bullish insider, and their stock value gained 11% last week

(17 Apr 2025)
Key Insights Gufic Biosciences' significant insider ownership suggests inherent interests in company's expansion The...
Read more →